BR9908301A - Derivados de indol e composições farmacêuticas que compreendem os mesmos - Google Patents

Derivados de indol e composições farmacêuticas que compreendem os mesmos

Info

Publication number
BR9908301A
BR9908301A BR9908301-9A BR9908301A BR9908301A BR 9908301 A BR9908301 A BR 9908301A BR 9908301 A BR9908301 A BR 9908301A BR 9908301 A BR9908301 A BR 9908301A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
same
indole derivatives
eye strain
ethyl
Prior art date
Application number
BR9908301-9A
Other languages
English (en)
Inventor
Makio Kiazawa
Toshiaki Yamaguchi
Hiroshi Miyata
Yukiyoshi Ajisawa
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of BR9908301A publication Critical patent/BR9908301A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"DERIVADOS DE INDOL E COMPOSIçõES FARMACêUTICAS QUE COMPREENDEM OS MESMOS" Trata-se de derivados de indol representados pela fórmula geral (I) ou seus sais farmaceuticamente aceitáveis, que têm um efeito notável e prolongado de redução de tensão ocular e são, portanto, úteis como medicamentos para reduzir a tensão ocular. Na fórmula, R representa etila ou 2,2,2-trifluoro etila; Y representa hidróxi ou pivaloilóxi; e o átomo de carbono marcado com (R) significa que tem a configuração em R.
BR9908301-9A 1998-02-27 1999-02-19 Derivados de indol e composições farmacêuticas que compreendem os mesmos BR9908301A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9057298 1998-02-27
PCT/JP1999/000732 WO1999043652A1 (fr) 1998-02-27 1999-02-19 Derives de l'indole et compositions medicales les renfermant

Publications (1)

Publication Number Publication Date
BR9908301A true BR9908301A (pt) 2000-10-31

Family

ID=14002150

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908301-9A BR9908301A (pt) 1998-02-27 1999-02-19 Derivados de indol e composições farmacêuticas que compreendem os mesmos

Country Status (24)

Country Link
US (1) US6310086B1 (pt)
EP (1) EP1057813B1 (pt)
JP (1) JP4342101B2 (pt)
KR (1) KR100576207B1 (pt)
CN (1) CN1157375C (pt)
AR (1) AR014964A1 (pt)
AT (1) ATE264841T1 (pt)
AU (1) AU766088B2 (pt)
BR (1) BR9908301A (pt)
CA (1) CA2321547C (pt)
DE (1) DE69916586T2 (pt)
DK (1) DK1057813T3 (pt)
ES (1) ES2220043T3 (pt)
HK (1) HK1036974A1 (pt)
HU (1) HUP0100680A3 (pt)
NO (1) NO317257B1 (pt)
NZ (1) NZ506497A (pt)
PE (1) PE20000329A1 (pt)
PL (1) PL342477A1 (pt)
RU (1) RU2212404C2 (pt)
SK (1) SK12722000A3 (pt)
TW (2) TWI249525B (pt)
WO (1) WO1999043652A1 (pt)
ZA (1) ZA991590B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL342477A1 (en) 1998-02-27 2001-06-04 Kissei Pharmaceutical Derivatives of indole and pharmacological compositions containing them
JP4634560B2 (ja) * 2000-01-14 2011-02-16 キッセイ薬品工業株式会社 光学活性なインドリン誘導体の製造方法およびその製造中間体
AU2001256714A1 (en) * 2000-05-15 2001-11-26 Kissei Pharmaceutical Co. Ltd. Water-based liquid preparation
AU2001256733A1 (en) * 2000-05-16 2001-11-26 Takeda Chemical Industries Ltd. Melanin-concentrating hormone antagonist
JP4921646B2 (ja) * 2001-03-08 2012-04-25 キッセイ薬品工業株式会社 １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法
CA2453476A1 (en) * 2001-07-13 2003-01-23 Kissei Pharmaceutical Co., Ltd. Medicinal compositions for opthalmic use
HU225505B1 (en) * 2002-09-09 2007-01-29 Richter Gedeon Vegyeszet Process for the preparation of r-(-)-tamsulosin hydrochloride and novel intermediates
AR050253A1 (es) 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
BRPI0517515B8 (pt) * 2004-10-27 2021-05-25 Kissei Pharmaceutical composto de indolina, bem como métodos para produção de compostos de indolina
WO2006137368A1 (ja) * 2005-06-21 2006-12-28 Kowa Co., Ltd. 緑内障の予防又は治療剤
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
EP2125717B1 (en) * 2007-02-26 2013-07-03 Concert Pharmaceuticals Inc. Deuterated derivatives of silodosin as alpha ia-adrenoreceptor antagonists
US20100076010A1 (en) * 2007-02-26 2010-03-25 Concert Pharmaceuticals, Inc. Alpha 1a-adrenoceptor antagonists
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
US8354539B2 (en) 2009-03-10 2013-01-15 Glaxo Group Limited Indole derivatives as IKK2 inhibitors
CN104211631A (zh) * 2013-05-30 2014-12-17 中国科学院上海药物研究所 一类吲哚类化合物、其制备方法、药物组合物及应用
WO2016042441A1 (en) 2014-09-18 2016-03-24 Mankind Research Centre A novel process for the preparation of considerably pure silodosin
ES2607639B1 (es) 2015-09-30 2018-02-28 Urquima, S.A Sal de ácido maleico de un intermedio de silodosina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021410A (en) * 1989-05-22 1991-06-04 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
DE69319551T2 (de) * 1992-12-02 1998-10-29 Kissei Pharmaceutical Indolin Verbindungen zur Behandlung von Dysurien
JP3331047B2 (ja) * 1994-06-01 2002-10-07 キッセイ薬品工業株式会社 インドリン誘導体
JP3331048B2 (ja) * 1994-06-01 2002-10-07 キッセイ薬品工業株式会社 インドール誘導体
JPH08143557A (ja) * 1994-11-24 1996-06-04 Toyobo Co Ltd 新規なフェニルピペラジン誘導体、その塩及びその溶媒和物
JPH0912563A (ja) * 1995-06-30 1997-01-14 Toyobo Co Ltd 新規ベンジルアルコ−ル誘導体、その製造方法およびその用途
WO1999015202A1 (fr) * 1997-09-22 1999-04-01 Kissei Pharmaceutical Co., Ltd. Medicaments contre la dysurie resultant d'une hypertrophie de la prostate
PL342477A1 (en) 1998-02-27 2001-06-04 Kissei Pharmaceutical Derivatives of indole and pharmacological compositions containing them

Also Published As

Publication number Publication date
WO1999043652A1 (fr) 1999-09-02
ATE264841T1 (de) 2004-05-15
KR20010041403A (ko) 2001-05-15
NO20004277D0 (no) 2000-08-25
TWI241293B (en) 2005-10-11
CA2321547A1 (en) 1999-09-02
JP4342101B2 (ja) 2009-10-14
HUP0100680A2 (hu) 2001-08-28
CA2321547C (en) 2010-01-19
NZ506497A (en) 2004-12-24
CN1157375C (zh) 2004-07-14
AR014964A1 (es) 2001-04-11
US6310086B1 (en) 2001-10-30
DE69916586D1 (de) 2004-05-27
HK1036974A1 (en) 2002-01-25
DK1057813T3 (da) 2004-08-16
NO317257B1 (no) 2004-09-27
RU2212404C2 (ru) 2003-09-20
EP1057813A1 (en) 2000-12-06
KR100576207B1 (ko) 2006-05-03
SK12722000A3 (sk) 2001-03-12
EP1057813A4 (en) 2001-11-21
ZA991590B (en) 1999-08-27
ES2220043T3 (es) 2004-12-01
EP1057813B1 (en) 2004-04-21
AU766088B2 (en) 2003-10-09
PE20000329A1 (es) 2000-04-13
AU2547899A (en) 1999-09-15
NO20004277L (no) 2000-09-11
PL342477A1 (en) 2001-06-04
TWI249525B (en) 2006-02-21
CN1291976A (zh) 2001-04-18
HUP0100680A3 (en) 2001-09-28
DE69916586T2 (de) 2004-09-16

Similar Documents

Publication Publication Date Title
BR9908301A (pt) Derivados de indol e composições farmacêuticas que compreendem os mesmos
BR0313562A (pt) derivados de indol ou benzimidazol para a modulação da ikb-cinase
BR9912098A (pt) Derivado de tiobenzimidazol, composição farmacêutica, e, agente preventivo e/ou terapêutico
BRPI0511967A (pt) usos de derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetrahidro-2h-pirido[2,3-d] pirimidina e compostos relacionados para o tratamento de cáncer, suas composições farmacêuticas, embalagens comerciais e respectivo kit
BRPI0313942C1 (pt) derivados de benzimidazol úteis como agentes antiproliferativos, seus processos de preparação, composição farmacêutica compreendendo os mesmos e usos dos referidos compostos nas preparações de composições farmacêuticas
BR9905788A (pt) Derivados de 2-(2-oxo-etilideno)-imidazolidin-4-ona e composições e métodos para a inibição do crescimento de célula anormal que compreendem os referidos derivados
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
MA27040A1 (fr) Nucleosides substitues en 4'
BR0107811A (pt) Composição herbicida
BR0312729A (pt) Novos derivados de indol-3-enxofre
BR9913138A (pt) Derivados de quinolin-2-ona substituìdos com alquinila úteis como agentes contra o câncer
BR0109703A (pt) Derivados de piperazina
BR0015026A (pt) Indóis substituìdos para a modulação da atividade de nfkb
CL2010000606A1 (es) Uso de derivados de eritropoyetina en la preparacion de un medicamento util para proteger, mantener, mejorar o recuperar la viabilidad de celulas que responden a eritropoyetina en condiciones anomalas que afectan las celulas, tejidos u organos asociados; derivados de eritropoyetinas y composicion que las comprende (divisional de la solicitud 3188-2001).
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BRPI0608291A2 (pt) agente imunossupressor e agente antitumoral que compreendem composto heterocìclico como ingrediente ativo
BRPI0504445A (pt) composição de trombina e processo para a sua preparação
AR028810A1 (es) Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion
BR9809468A (pt) Formulações farmacêuticas contendo voriconazol
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
BR9810450A (pt) Derivados de ácido barbitúrico com atividade antimetastática e antitumor
PE20050822A1 (es) Derivados de florfenicol con mejor solubilidad en agua
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1971 DE 14/10/2008.